Clinical Trial Update: A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers [Phase 1]

View source ↗

Summary

This document reports a Phase 1 clinical trial of NI-1801 for mesothelin-expressing solid cancers, with recruiting status and multiple indications including ova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrioid Ovarian Cancer
• Epithelial Ovarian Cancer
• Non-small Cell Lung Cancer
• Pancreatic Ductal Adenocarcinoma
• Triple-negative Breast Cancer

Drugs mentioned

• NI-1801

Snippet

Sponsor: Light Chain Bioscience - Novimmune SA | Conditions: Epithelial Ovarian Cancer, Triple Negative Breast Cancer | Phase 1 | Status: RECRUITING